113 related articles for article (PubMed ID: 16843659)
1. Identification of novel pyrazole acid antagonists for the EP1 receptor.
McKeown SC; Hall A; Giblin GM; Lorthioir O; Blunt R; Lewell XQ; Wilson RJ; Brown SH; Chowdhury A; Coleman T; Watson SP; Chessell IP; Pipe A; Clayton N; Goldsmith P
Bioorg Med Chem Lett; 2006 Sep; 16(18):4767-71. PubMed ID: 16843659
[TBL] [Abstract][Full Text] [Related]
2. SAR-based optimization of 2-(1H-pyrazol-1-yl)-thiazole derivatives as highly potent EP1 receptor antagonists.
Atobe M; Naganuma K; Kawanishi M; Morimoto A; Kasahara K; Ohashi S; Suzuki H; Hayashi T; Miyoshi S
Bioorg Med Chem Lett; 2013 Dec; 23(24):6569-76. PubMed ID: 24252546
[TBL] [Abstract][Full Text] [Related]
3. Non-acidic pyrazole EP1 receptor antagonists with in vivo analgesic efficacy.
Hall A; Billinton A; Brown SH; Clayton NM; Chowdhury A; Giblin GM; Goldsmith P; Hayhow TG; Hurst DN; Kilford IR; Naylor A; Passingham B; Winyard L
Bioorg Med Chem Lett; 2008 Jun; 18(11):3392-9. PubMed ID: 18462938
[TBL] [Abstract][Full Text] [Related]
4. Discovery of novel pyrazolo[1,5-a]pyridine-based EP
Nishigaya Y; Umei K; Saito Y; Watanabe H; Kondo T; Kondo A; Kawamura N; Tatani K; Kohno Y; Tanaka N; Seto S
Bioorg Med Chem Lett; 2017 Sep; 27(17):4044-4050. PubMed ID: 28784294
[TBL] [Abstract][Full Text] [Related]
5. Discovery of brain penetrant, soluble, pyrazole amide EP1 receptor antagonists.
Hall A; Billinton A; Bristow AK; Brown SH; Chowdhury A; Cutler L; Giblin GM; Goldsmith P; Hayhow TG; Kilford IR; Naylor A; Passingham B; Rawlings DA
Bioorg Med Chem Lett; 2008 Jul; 18(14):4027-32. PubMed ID: 18571922
[TBL] [Abstract][Full Text] [Related]
6. Hit-to-lead optimization of 2-(1H-pyrazol-1-yl)-thiazole derivatives as a novel class of EP1 receptor antagonists.
Atobe M; Naganuma K; Kawanishi M; Morimoto A; Kasahara K; Ohashi S; Suzuki H; Hayashi T; Miyoshi S
Bioorg Med Chem Lett; 2013 Nov; 23(22):6064-7. PubMed ID: 24094816
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a novel indole series of EP1 receptor antagonists by scaffold hopping.
Hall A; Billinton A; Brown SH; Chowdhury A; Giblin GM; Goldsmith P; Hurst DN; Naylor A; Patel S; Scoccitti T; Theobald PJ
Bioorg Med Chem Lett; 2008 Apr; 18(8):2684-90. PubMed ID: 18378447
[TBL] [Abstract][Full Text] [Related]
8. Discovery of a series of acrylic acids and their derivatives as chemical leads for selective EP3 receptor antagonists.
Asada M; Obitsu T; Nagase T; Sugimoto I; Yamaura Y; Sato K; Narita M; Ohuchida S; Nakai H; Toda M
Bioorg Med Chem; 2009 Sep; 17(18):6567-82. PubMed ID: 19700331
[TBL] [Abstract][Full Text] [Related]
9. Novel pyrazolo[1,5-a]pyridines as orally active EP
Umei K; Nishigaya Y; Kondo A; Tatani K; Tanaka N; Kohno Y; Seto S
Bioorg Med Chem; 2017 May; 25(9):2635-2642. PubMed ID: 28342692
[TBL] [Abstract][Full Text] [Related]
10. The discovery of 6-[2-(5-chloro-2-{[(2,4-difluorophenyl)methyl]oxy}phenyl)-1-cyclopenten-1-yl]-2-pyridinecarboxylic acid, GW848687X, a potent and selective prostaglandin EP1 receptor antagonist for the treatment of inflammatory pain.
Giblin GM; Bit RA; Brown SH; Chaignot HM; Chowdhury A; Chessell IP; Clayton NM; Coleman T; Hall A; Hammond B; Hurst DN; Michel AD; Naylor A; Novelli R; Scoccitti T; Spalding D; Tang SP; Wilson AW; Wilson R
Bioorg Med Chem Lett; 2007 Jan; 17(2):385-9. PubMed ID: 17084082
[TBL] [Abstract][Full Text] [Related]
11. Novel methylene-linked heterocyclic EP1 receptor antagonists.
Hall A; Bit RA; Brown SH; Chowdhury A; Giblin GM; Hurst DN; Kilford IR; Lewell X; Naylor A; Scoccitti T
Bioorg Med Chem Lett; 2008 Mar; 18(5):1592-7. PubMed ID: 18262416
[TBL] [Abstract][Full Text] [Related]
12. Discovery of new chemical leads for selective EP1 receptor antagonists.
Naganawa A; Saito T; Nagao Y; Egashira H; Iwahashi M; Kambe T; Koketsu M; Yamamoto H; Kobayashi M; Maruyama T; Ohuchida S; Nakai H; Kondo K; Toda M
Bioorg Med Chem; 2006 Aug; 14(16):5562-77. PubMed ID: 16697646
[TBL] [Abstract][Full Text] [Related]
13. Structure-activity relationships of 1,5-biaryl pyrroles as EP1 receptor antagonists.
Hall A; Atkinson S; Brown SH; Chessell IP; Chowdhury A; Clayton NM; Coleman T; Giblin GM; Gleave RJ; Hammond B; Healy MP; Johnson MR; Michel AD; Naylor A; Novelli R; Spalding DJ; Tang SP
Bioorg Med Chem Lett; 2006 Jul; 16(14):3657-62. PubMed ID: 16697196
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting.
Guan Y; Zhang Y; Wu J; Qi Z; Yang G; Dou D; Gao Y; Chen L; Zhang X; Davis LS; Wei M; Fan X; Carmosino M; Hao C; Imig JD; Breyer RM; Breyer MD
J Clin Invest; 2007 Sep; 117(9):2496-505. PubMed ID: 17710229
[TBL] [Abstract][Full Text] [Related]
15. 1,5-Biaryl pyrrole derivatives as EP1 receptor antagonists. Structure-activity relationships of 6-substituted and 5,6-disubstituted benzoic acid derivatives.
Hall A; Brown SH; Chessell IP; Chowdhury A; Clayton NM; Coleman T; Giblin GM; Hammond B; Healy MP; Johnson MR; Metcalf A; Michel AD; Naylor A; Novelli R; Spalding DJ; Sweeting J; Winyard L
Bioorg Med Chem Lett; 2007 Feb; 17(4):916-20. PubMed ID: 17175160
[TBL] [Abstract][Full Text] [Related]
16. EP1- and EP3-receptors mediate prostaglandin E2-induced constriction of porcine large cerebral arteries.
Jadhav V; Jabre A; Lin SZ; Lee TJ
J Cereb Blood Flow Metab; 2004 Dec; 24(12):1305-16. PubMed ID: 15625406
[TBL] [Abstract][Full Text] [Related]
17. Roles of prostaglandin E receptors in mesangial cells under high-glucose conditions.
Ishibashi R; Tanaka I; Kotani M; Muro S; Goto M; Sugawara A; Mukoyama M; Sugimoto Y; Ichikawa A; Narumiya S; Nakao K
Kidney Int; 1999 Aug; 56(2):589-600. PubMed ID: 10432398
[TBL] [Abstract][Full Text] [Related]
18. Characterization and regulation of prostaglandin E2 receptor and receptor-coupled functions in the choroidal vasculature of the pig during development.
Abran D; Dumont I; Hardy P; Peri K; Li DY; Molotchnikoff S; Varma DR; Chemtob S
Circ Res; 1997 Apr; 80(4):463-72. PubMed ID: 9118476
[TBL] [Abstract][Full Text] [Related]
19. Identification of novel glycine sulfonamide antagonists for the EP1 receptor.
McKeown SC; Hall A; Blunt R; Brown SH; Chessell IP; Chowdhury A; Giblin GM; Healy MP; Johnson MR; Lorthioir O; Michel AD; Naylor A; Lewell X; Roman S; Watson SP; Winchester WJ; Wilson RJ
Bioorg Med Chem Lett; 2007 Mar; 17(6):1750-4. PubMed ID: 17236765
[TBL] [Abstract][Full Text] [Related]
20. Role of prostaglandin receptor subtype EP1 in prostaglandin E2-induced nociceptive transmission in the rat spinal dorsal horn.
Nakayama Y; Omote K; Kawamata T; Namiki A
Brain Res; 2004 Jun; 1010(1-2):62-8. PubMed ID: 15126118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
